Real-time enrollment status for this myelofibrosis due to and following polycythemia vera clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:50 AM UTC
| NCT Number | NCT05714072 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis Due to and Following Polycythemia Vera |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | November 18, 2025 (Nov 18, 2025) |
As of July 13, 2026: Clinical trial NCT05714072 is currently recruiting participants. This clinical trial study for myelofibrosis due to and following polycythemia vera is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05714072 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05714072 was last updated Nov 18, 2025 (November 18, 2025). HelloStudys verifies this status automatically.